THE CONTROL OF GONADOTROPHIN RELEASE IN WOMEN WITH HYPERPROLACTINAEMIC AMENORRHOEA: EFFECT OF OESTROGEN AND PROGESTERONE ON THE LH AND FSH RESPONSE TO LHRH
- 1 September 1976
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 5 (5) , 521-530
- https://doi.org/10.1111/j.1365-2265.1976.tb01981.x
Abstract
The effect of the administration of estradiol benzoate and of progesterone on the subsequent response to LHRH [luteinizing hormone-releasing hormone] was investigated in women with hyperprolactinemia. There was an amplification in the release of LH [luteinizing hormone] in 4 of 10 patients and of FSH [follicle-stimulating hormone] in 1 of 10 patients at 44 h after the administration of 2.5 mg estradiol benzoate. The average amount of LH released before and after estrogen did not change, but there was a significant decrease in the amount of FSH released. There was no correlation between the LH released and the estradiol concentration in serum at the time of the LHRH tests, but there was a negative correlation between the FSH released and the estradiol concentration (r = 0.507; P < 0.05). These results contrast with those obtained in normal subjects in the follicular phase of the cycle when there is a positive correlation of estrogen concentrations and the amount of LH and FSH released. As in normal subjects, however, a significant suppression of basal FSH concentrations, persisting until 44 h, was produced by estrogen (P < 0.01). Out of 11 patients, 7 showed an amplification of LH response and 6 of 11 an FSH response 20 h after the administration of 25 mg progesterone. The mean amplifications are not significantly different from those of normal subjects tested in the early follicular phase of the cycle, but are significantly less than those tested in the mid follicular phase of the cycle (LH P < 0.001; FSH P < 0.01). This may be related to the serum concentrations of estradiol which in patients with hyperprolactinemia are significantly less than those found in the mid follicular phase of the cycle (P < 0.05). In women with hyperprolactinemia estrogen negative feedback, necessary for cycle initiation, is probably normal: failure of ovulation may be related to failure of positive feedback to estrogen. Estrogen-negative feedback is unopposed, and this may explain the follicular development and lack of estrogen in the mid-follicular phase.This publication has 23 references indexed in Scilit:
- CLINICAL AND ENDOCRINE FEATURES OF HYPERPROLACTINAEMIC AMENORRHOEAClinical Endocrinology, 1976
- BASAL SERUM PROLACTIN VALUES AND RESPONSES TO THE ADMINISTRATION OF THYROTROPHIN RELEASING HORMONE (TRH) IN WOMEN WITH AMENORRHOEABJOG: An International Journal of Obstetrics and Gynaecology, 1976
- Hyperprolactinemic Anovulatory Syndrome*Journal of Clinical Endocrinology & Metabolism, 1976
- An abnormality of oestrogen feedback in amenorrhoea-galactorrhoea.BMJ, 1975
- DRUGS THAT AFFECT THE BREAST AND LACTATIONClinical Obstetrics and Gynecology, 1975
- EFFECT OF GONADAL STEROIDS ON THE PITUITARY RESPONSIVENESS TO SYNTHETIC LUTEINIZING HORMONE RELEASING HORMONE IN THE MALE DOGJournal of Endocrinology, 1974
- Direct Action of Synthetic Progestins on the Hypophysis1Endocrinology, 1973
- Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptineBMJ, 1972
- Effect of Estradiol and Progesterone on the LH Release Induced by LH-Releasing Hormone (LH-RH) in Intact Diestrous Rats and Anestrous EwesExperimental Biology and Medicine, 1972
- Simultaneous Radioimmunoassay of Plasma FSH, LH, Progesterone, 17-Hydroxyprogesterone, and Estradiol-17β During the Menstrual CycleJournal of Clinical Endocrinology & Metabolism, 1972